Inhibition of phosphoinositide 3-kinase p110delta does not affect t cell driven development of type 1 diabetes despite significant effects on cytokine production

HIGHLIGHTS

• who: Ariana Barbera Betancourt and collaborators from the Department of Pathology, University of Cambridge, Tennis Court Road, QP Cambridge, United School of Medicine, Cardiff University, Cardiff , XN, United Kingdom have published the article: Inhibition of Phosphoinositide 3-Kinase p110delta Does Not Affect T Cell Driven Development of Type 1 Diabetes Despite Significant Effects on Cytokine Production, in the Journal: PLOS ONE | DOI:10.1371/journal.pone [0146516]. January 19, 2016 of /1371/
• what: The authors demonstrate that combination treatment with CTLA4-Ig does not improve the efficacy of treatment but instead attenuates the protective effects . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.